NUCLEOLIN and neoplasm: For example, the tumor receptor-based target strategy 6 involves attachment of specific tumor recognition elements to anticancer compounds, such as antibodies 7, amino acids 8, folic acid 9 and nucleolin aptamers 10, which are overexpressed (or their receptors are overexpressed) or specifically expressed at tumor sites.